Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Tadalafil Tablets

Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Terminated cGMP deviation Sun Pharmaceutical Industries INC NDC 16714-077-01 D-0231-2022
Class II · Moderate risk

Tadalafil Tablets

Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Terminated cGMP deviation Sun Pharmaceutical Industries INC NDC 16714-075-01 D-0230-2022
Class II · Moderate risk

Pregabalin Capsules

Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

Terminated Failed specification Sun Pharmaceutical Industries INC NDC 47335-687-88 D-0361-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity

Terminated Failed specification Golden State Medical Supply Inc. NDC 51407-193-05 D-0228-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022

Recalls by year